Dramatic Results Seen With Gene Therapy for Age-Related Macular Degeneration
MONTREAL — Gene therapy for neovascular age-related macular degeneration (nAMD) achieved stable vision and retinal anatomy for up to 5 years, with dramatic reductions in treatment burden, according to studies…
